Botulinum toxin A - Mentor Corporation

Drug Profile

Botulinum toxin A - Mentor Corporation

Alternative Names: Botulinum toxin A - Mentor Worldwide; PurTox

Latest Information Update: 19 Apr 2016

Price : *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Mentor Corporation
  • Developer Mentor Worldwide
  • Class Antispasmodics; Bacterial proteins; Bacterial toxins; Botulinum toxins; Muscle relaxants
  • Mechanism of Action Acetylcholine inhibitors; Glutamate-antagonists; Neuromuscular blocking agents
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity Yes

Highest Development Phases

  • Discontinued Skin disorders; Torticollis

Most Recent Events

  • 15 Mar 2016 Biomarkers information updated
  • 01 Jan 2014 No development reported - Phase-I/II for Torticollis in USA (IM)
  • 01 Jun 2007 Phase-III clinical trials in Skin disorders (glabellar rhytides) in USA (IM)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top